The Rise and Fall of the Next-Generation Obesity Drug

Novo Nordisk's drug, wagovi, was the first of these new obesity drugs to get approval. But at ADA, Eli Lilly released a bunch of new data on several different obesity products that really wowed people. So coming out of ADA, Lilly looks to be a lot more competitive and perhaps is starting to gain an edge over Novo-Nortisk.